Press Release
Preimplantation Genetics Diagnosis (PGD) Market is Estimated to Reach $140 Million by 2024, Says Variant Market Research
 Published Date:  Sep 2017  Publish By: Variant Market Research

Global Preimplantation Genetics Diagnosis (PGD) Market Report, published by Variant Market Research, forecast that the global market is expected to reach $140 Million by 2024 from $86 Million in 2016, growing at a CAGR of 6.2% from 2016 to 2024. By geography, North America and Asia-Pacific are expected to grow at a CAGR of 6.7% and 6.4%, respectively, during the forecast period.

"Preimplantation Genetics Diagnosis (PGD) Market (By Test Type: Gender Selection, Chromosomal Abnormalities, Single Gene Disorders, HLA Typing, Aneuploidy, X-Linked Diseases, And Others; By Geography: North America, Europe, Asia-Pacific and RoW) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024"

To browse the complete report, visit at: https://www.variantmarketresearch.com/report-categories/medical-devices/preimplantation-genetics-diagnosis-market

Some of the factors driving the growth of the global preimplantation genetics diagnosis (PGD) market are declining fertility rate, advancements in the field of genetic analysis, increasing occurrence of genetic disorders, rising demand of IVF treatments, and high possibility of genetic abnormalities in embryos with progressing maternal age. Factors such as stringent government regulations and social-economic concerns would limit the growth of the market. However, rising R&D and market expansion would provide market opportunities in the coming years.

Test type and geography are the major bifurcations in the global preimplantation genetics diagnosis (PGD) market. Test type is further categorized as gender selection, chromosomal abnormalities, single gene disorders, HLA typing, aneuploidy, X-linked diseases, and other test types. Among which, chromosomal abnormalities accounted the largest market share, whereas, other test types shall attain the fastest CAGR during the forecast period 2016–2024.

Geographically, global preimplantation genetics diagnosis (PGD) market is bifurcated into North America, Europe, Asia Pacific, and RoW. Europe and North America accounted the maximum market share in 2016, with 31.5% and 26.8% respectively. In terms of growth, North America would dominate with fastest CAGR during the forecast period, driven by, high awareness among people regarding availability of such treatment, increasing infertility rate, and rising investments by government organizations.

Major market players include Abbott Laboratories, Natera, Inc., PerkinElmer, Inc., Illumina, Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., PerkinElmer, Inc., Cooper Surgical, Inc., and Beijing Genomics Institute (BGI), among others.

Contact Us:

John Dave,
Head - Sales 
Variant Market Research
649 Mission St, 5th Floor, San Francisco, CA 94105, United States.
Tel: +91-953-444-8373
Email: john.dave@variantmarketresearch.com 
Email: help@variantmarketresearch.com


GET MORE INFORMATION ABOUT THIS REPORT


Refresh Captcha

Chapter 1 Prefix
    1.1 Market Scope
    1.2 Report Description
    1.3 Research Methodology
          1.3.1 Primary Research
          1.3.2 Secondary Research
          1.3.3 In-house Data Modeling
Chapter 2 Executive Summary
Chapter 3 Market Outline
    3.1 Market Inclination, Trend, Outlook and Viewpoint
    3.2 Market Share Analysis: Company’s Competitive Scenario
    3.3 Market Dynamics
          3.3.1 Drivers
                   3.3.1.1 Impact Analysis
          3.3.2 Restraints
                   3.3.2.1 Impact Analysis
          3.3.3 Opportunities
Chapter 4 Preimplantation Genetics Diagnosis (PGD) Market by Test Type: Market Size and Forecast, 2015 – 2024
    4.1 Overview
    4.2 Gender Selection
          4.2.1 Current Trend and Analysis
          4.2.2 Market Size and Forecast
    4.3 Chromosomal Abnormalities
          4.3.1 Current Trend and Analysis
          4.3.2 Market Size and Forecast
    4.4 Single Gene Disorders
          4.4.1 Current Trend and Analysis
          4.4.2 Market Size and Forecast
    4.5 HLA Typing
          4.5.1 Current Trend and Analysis
          4.5.2 Market Size and Forecast
    4.6 Aneuploidy
          4.6.1 Current Trend and Analysis
          4.6.2 Market Size and Forecast
    4.7 X-Linked Diseases
          4.7.1 Current Trend and Analysis
          4.7.2 Market Size and Forecast
    4.8 Other Test Types
          4.8.1 Current Trend and Analysis
          4.8.2 Market Size and Forecast
Chapter 5 Preimplantation Genetics Diagnosis (PGD) Market by Geography: Market Size and Forecast, 2015 – 2024
    5.1 Overview
    5.2 North America
          5.2.1 Current Trend and Analysis
          5.2.2 Market Size and Forecast
          5.2.3 U.S.
                   5.2.3.1 Market Size and Forecast
          5.2.4 Canada
                   5.2.4.1 Market Size and Forecast
          5.2.5 Mexico
                   5.2.5.1 Market Size and Forecast
    5.3 Europe
          5.3.1 Current Trend and Analysis
          5.3.2 Market Size and Forecast
          5.3.3 UK
                   5.3.3.1 Market Size and Forecast
          5.3.4 Germany
                   5.3.4.1 Market Size and Forecast
          5.3.5 France
                   5.3.5.1 Market Size and Forecast
          5.3.6 Others
                   5.3.6.1 Market Size and Forecast
    5.4 Asia-Pacific
          5.4.1 Current Trend and Analysis
          5.4.2 Market Size and Forecast
          5.4.3 India
                   5.4.3.1 Market Size and Forecast
          5.4.4 China
                   5.4.4.1 Market Size and Forecast
          5.4.5 Japan
                   5.4.5.1 Market Size and Forecast
          5.4.6 Others
                   5.4.6.1 Market Size and Forecast
    5.5 RoW
          5.5.1 Current Trend and Analysis
          5.5.2 Market Size and Forecast
          5.5.3 Middle East
                   5.5.3.1 Market Size and Forecast
          5.5.4 South America
                   5.5.4.1 Market Size and Forecast
          5.5.5 Africa
                   5.5.5.1 Market Size and Forecast
Chapter 6 Company Profiles
    6.1 Abbott Laboratories
    6.2 Natera, Inc.
    6.3 PerkinElmer, Inc.
    6.4 Illumina, Inc.
    6.5 F. Hoffmann-La Roche AG
    6.6 Thermo Fisher Scientific, Inc.
    6.7 Agilent Technologies, Inc.
    6.8 PerkinElmer, Inc.
    6.9 Cooper Surgical, Inc.
    6.10 Beijing Genomics Institute (BGI)

GET MORE INFORMATION ABOUT THIS REPORT


Refresh Captcha

Please fill the form below and our research expert will get in touch with you.


Refresh Captcha

Please fill the form below and our research expert will get in touch with you.


Refresh Captcha